Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $142.46M.
ENTERPRISE VALUE (EV)
$142.46M
Minerva Neurosciences, Inc.
Market Cap
$159.80M
Enterprise Value (EV)
$142.46M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $159.80M | $142.46M |
| PepGen Inc. (PEPG)vs › | $159.78M | $153.11M |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | $140.10M |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | $113.92M |
| Quanterix Corporation (QTRX)vs › | $162.04M | $151.26M |
| Inogen, Inc. (INGN)vs › | $156.22M | $84.74M |
| Nkarta, Inc. (NKTX)vs › | $165.27M | $213.85M |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | $160.70M |
| Neuronetics, Inc. (STIM)vs › | $153.79M | $221.12M |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | $170.95M |
Market Cap
$159.80M
Total Debt
$64.96M
Cash
$82.30M
Enterprise Value
$142.46M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
